Blog
RSS FeedPosted by Michael Wonder on 15 Mar 2018
Proposal to fund denosumab for osteoporosis
16 March 2018 - PHARMAC is proposing to fund denosumab (Prolia) injections from 1 June 2018 for the treatment of severe, ...
Posted by Michael Wonder on 15 Mar 2018
Decision to open list montelukast tablets
15 March 2018 - PHARMAC will remove the Special Authority and Hospital Medicine restrictions on montelukast 4 mg, 5 mg ...
Posted by Michael Wonder on 15 Mar 2018
PHARMAC publishes indicative agenda for May 2018 PTAC meeting
15 March 2018 - The May 2018 PTAC meeting will review the following applications for several new medicines. ...
Posted by Michael Wonder on 11 Mar 2018
Proposal to widen access and change the funded brand of tenofovir disoproxil and entecavir
9 March 2018 - PHARMAC is delighted to propose the widening of access to tenofovir disoproxil and entecavir, anti-viral medicines ...
Posted by Michael Wonder on 07 Mar 2018
Cancer sufferers want Oz treatments: 'I want to live'
7 March 2018 - A Tauranga woman with terminal breast cancer has had to fundraise over $100,000 to pay for a ...
Posted by Michael Wonder on 07 Mar 2018
Decision to change the funded brand of aripiprazole and remove listing restrictions
7 March 2018 - PHARMAC is pleased to announce the approval of an agreement with Novartis New Zealand Limited for ...
Posted by Michael Wonder on 28 Feb 2018
New Zealand Pharmaceutical Schedule - 1 March 2018
1 March 2018 - The March 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 22 Feb 2018
New insights on PHARMAC's tardiness in funding Keytruda for patients with NSCLC
21 February 2018 - The minutes from the November 2017 PTAC meeting note further information from MSD, submitted in response ...
Posted by Michael Wonder on 22 Feb 2018
Minutes from November 2017 PTAC meeting provide interesting insights on Roche's submission for Kadcyla
21 February 2018 - The minutes need to be read carefully as they start with a subcommittee outcome. ...
Posted by Michael Wonder on 21 Feb 2018
Charity upset pre-election pledge for separate fund for rare diseases off the table
21 February 2018 - The country's biggest charity helping people dealing with rare disorders is upset the Government has gone ...
Posted by Michael Wonder on 19 Feb 2018
New Zealand cancer survival rate worse than Australia's
19 February 2018 - About 2500 New Zealanders would have beaten cancer in the last five years if they had ...
Posted by Michael Wonder on 11 Feb 2018
Cancer patients waiting a year for Keytruda funding decision from PHARMAC
12 February 2018 - Hundreds of lung cancer patients whose lives could be saved by a new treatment labelled a ...
Posted by Michael Wonder on 07 Feb 2018
No political pressure in HIV drug funding call - PHARMAC
7 February 2018 - PHARMAC is rejecting any suggestion it reacted to political pressure to fund a new anti-HIV drug. ...
Posted by Michael Wonder on 05 Feb 2018
New independent chair wants improved equitable access to breakthrough medicines
1 February 2018 - Former clinical leader, Dr. Lee Mathias, has been appointed as new chair for Medicines New Zealand ...
Posted by Michael Wonder on 01 Feb 2018
Advance notice of consultation about changes to the Pharmaceutical Schedule Rules
1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply. ...